Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of July 2017. The report addresses a procedural matter regarding the Company's Annual Meeting of Shareholders originally scheduled for July 25, 2017.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notice of a corporate event and does not contain financial statements or performance data.
Material Changes
No material financial changes are reported. The primary event is the adjournment of the Annual Meeting of Shareholders due to a lack of quorum.
Outlook and Corporate Events
- Meeting Adjournment: The Annual Meeting held on July 25, 2017, was adjourned for one week.
- Reconvened Meeting: The meeting is rescheduled for Tuesday, August 1, 2017, at 12:00 p.m. (Israel time).
- Location: The meeting will take place at the Company's offices at 10 Bareket Street, Petach Tikva, Israel.
Key Facts for Investors
- The Annual Meeting of Shareholders was not held on July 25, 2017, due to insufficient attendance (lack of quorum).
- Shareholders must attend the reconvened meeting on August 1, 2017, for corporate actions to proceed.
- This filing contains no financial results or operational updates beyond the meeting logistics.